Conventional therapies, including metformin, sulfonylureas, thiazolidinediones, and insulin, have proven effective in many instances, offering various mechanisms of action to address the underlying causes of T2DM, such as insulin resistance and beta-cell dysfunction. This evidence concerns the gene INS and Insulin resistance.